Home \ Projects \ Coalition for Epidemic Preparedness Innovations Phase II \ Mitigation of Biological Threats through Support for Vaccine Development

Mitigation of Biological Threats through Support for Vaccine Development

Project

Mitigation of Biological Threats through Support for Vaccine Development

Within the Vaccines Partnership (COVAX) of the Access to COVID-19 Tools (ACT)-Accelerator, CEPI is the designated lead for research, development, testing, and licensing of COVID-19 vaccines. The project is managing Canada’s C$60 million contribution to CEPI for COVID-19 vaccines for 2020.

Risk Area(s) covered

Activities

Beneficiary Countries

Beneficiary Regions

Budget

74000000 CAD

Status

Active
Start Date: January 1, 2017
End Date: December 31, 2021

ASI Database Release

Providers and Implementers ?

Related Projects & Programs

Parent Program: Coalition for Epidemic Preparedness Innovations Phase II

Contacts

Name Position Agency/Department/Org Note
Mr Trevor Smith Head & CWC Point of Contact
Global Partnership Program
Canada

Scroll to Top